| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.002 | 0.9 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |